BR112015014492A2 - composição de extrato de planta para tratamento de abuso de opióides e álcool - Google Patents

composição de extrato de planta para tratamento de abuso de opióides e álcool

Info

Publication number
BR112015014492A2
BR112015014492A2 BR112015014492A BR112015014492A BR112015014492A2 BR 112015014492 A2 BR112015014492 A2 BR 112015014492A2 BR 112015014492 A BR112015014492 A BR 112015014492A BR 112015014492 A BR112015014492 A BR 112015014492A BR 112015014492 A2 BR112015014492 A2 BR 112015014492A2
Authority
BR
Brazil
Prior art keywords
extract
opioid
treatment
alcohol
alcohol abuse
Prior art date
Application number
BR112015014492A
Other languages
English (en)
Other versions
BR112015014492B1 (pt
Inventor
Qadan Fadi
Original Assignee
Arabian German Medical Products Co W L L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arabian German Medical Products Co W L L filed Critical Arabian German Medical Products Co W L L
Publication of BR112015014492A2 publication Critical patent/BR112015014492A2/pt
Publication of BR112015014492B1 publication Critical patent/BR112015014492B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo “composição de extrato de planta para tratamento de abuso de opióides e álcool” a presente invenção refere-se a uma composição compreendendo a) um extrato de uma planta que pertence ao gênero raphanus, em que o referido extrato é obtenível ou obtido por extração de pelo menos as raízes aéreas, sementes e/ou bulbos com um solvente hidrofílico, médio polar e/ou lipofílico; b) um extrato de uma planta que pertence ao gênero theobroma, em que o referido extrato é obtenível ou obtido por extração pelo menos da fruta com um solvente hidrofílico e/ou médio polar, e c) um extrato de uma planta que pertence ao gênero passiflora, em que o referido extrato é obtenível ou obtido por extração pelo menos da flor com um solvente hidrofílico, a médio polar e/ou lipofílico, e a sua utilização no tratamento de abuso de opióides, dependência de opióides, dependência de álcool e/ou abuso de álcool e/ou para utilização em tratamento dos sintomas de abstinência de opióide e/ou álcool, e um método para a sua produção. 1/1
BR112015014492-6A 2012-12-20 2013-12-20 composição farmacêutica de extrato de planta para tratamento de abuso, dependência e sintomas de abstinência de álcool e/ou opioides BR112015014492B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12198729.1 2012-12-20
EP12198729 2012-12-20
PCT/IB2013/061217 WO2014097259A1 (en) 2012-12-20 2013-12-20 Composition comprising raphanus, theobroma and passiflora for treating opioid and alcohol abuse

Publications (2)

Publication Number Publication Date
BR112015014492A2 true BR112015014492A2 (pt) 2017-07-11
BR112015014492B1 BR112015014492B1 (pt) 2021-01-12

Family

ID=47519916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015014492-6A BR112015014492B1 (pt) 2012-12-20 2013-12-20 composição farmacêutica de extrato de planta para tratamento de abuso, dependência e sintomas de abstinência de álcool e/ou opioides

Country Status (8)

Country Link
US (1) US9821018B2 (pt)
EP (1) EP2934561B1 (pt)
JP (1) JP2016503787A (pt)
BR (1) BR112015014492B1 (pt)
CA (1) CA2893277C (pt)
EA (1) EA028508B1 (pt)
MX (1) MX371133B (pt)
WO (1) WO2014097259A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107630051B (zh) * 2017-10-12 2021-03-26 临沂大学 一种利用两相体系酶解与萃取偶联制备还原型萝卜硫素提取物的方法
KR102154074B1 (ko) 2018-10-17 2020-09-09 한국 한의학 연구원 플라보노이드계 화합물을 유효성분으로 포함하는 수면장애의 예방, 개선 또는 치료용 조성물
CN109917055B (zh) * 2019-03-29 2021-07-27 四川新绿色药业科技发展有限公司 一种王不留行与炒王不留行饮片、标准汤剂、配方颗粒的质量检测及鉴别方法
WO2022016097A1 (en) * 2020-07-16 2022-01-20 Musc Foundation For Research Development G9a inhibition decreases stress-induced and dependence-induced escalation of alcohol drinking

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4428740B2 (ja) 1998-09-14 2010-03-10 株式会社ロッテ ビフィズス菌増殖促進剤
RU2151610C1 (ru) * 1999-06-04 2000-06-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения алкогольной зависимости
JP2002113080A (ja) 2000-08-11 2002-04-16 Takasago Internatl Corp 消臭剤組成物およびその使用方法
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ES2274163T3 (es) * 2003-12-04 2007-05-16 Cognis Ip Management Gmbh Preparacion para su aplicacion (i) oral y/o topica.
JP4563186B2 (ja) * 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
FR2885300B1 (fr) * 2005-05-04 2007-07-20 Nuxe Sa Lab Composition topique pour la protection de l'epiderme
GB0719544D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
CN100551424C (zh) * 2007-05-31 2009-10-21 杨万政 一种用于解酒醒酒的中药组合物
JP2010001282A (ja) * 2008-05-23 2010-01-07 Kinjirushi Kk イソチオシアネート類含有組成物、食品、食品素材、医薬品、化粧品および日用品雑貨類。
CA2739610A1 (en) 2008-06-21 2009-12-23 Roger L. Waite Dna-directed customization of analgesic compounds as a therapeutic modality
CA2666446A1 (en) 2009-05-21 2010-11-21 Key Naturals Inc. Compositions for prostate and menstrual/menopausal related health
KR20110022882A (ko) * 2009-08-28 2011-03-08 남종현 온천수를 이용한 숙취 해소용 조성물 및 간 기능 회복용 조성물
KR20110115862A (ko) * 2010-04-16 2011-10-24 씨제이제일제당 (주) 숙취 해소 및 예방용 조성물과 이를 이용한 음주전 후 숙취해소용 음료
US20130165531A1 (en) * 2011-06-13 2013-06-27 E.P.C. (Beijing) Plant Pharmaceutical Technology Co., Ltd. Anthocyanin based colorant compositions
CN102784351B (zh) * 2012-08-30 2015-07-08 黄美钦 枣仁茯苓乌龙袋泡茶及其制作方法

Also Published As

Publication number Publication date
EA201591157A1 (ru) 2015-11-30
JP2016503787A (ja) 2016-02-08
US20150320815A1 (en) 2015-11-12
WO2014097259A1 (en) 2014-06-26
MX2015007991A (es) 2016-03-04
EA028508B1 (ru) 2017-11-30
BR112015014492B1 (pt) 2021-01-12
MX371133B (es) 2020-01-17
US9821018B2 (en) 2017-11-21
EP2934561A1 (en) 2015-10-28
CA2893277C (en) 2022-12-13
CA2893277A1 (en) 2014-06-26
EP2934561B1 (en) 2022-08-10

Similar Documents

Publication Publication Date Title
EA201890883A1 (ru) Вакуумная дистилляция для обогащения каннабидиола
BR112015014492A2 (pt) composição de extrato de planta para tratamento de abuso de opióides e álcool
ES2602992R1 (es) Composiciones y métodos para mejorar la producción de fruta
GT201500091A (es) Métodos y composiciones para el tratamiento y control de enfermedades en las plantas
Santana et al. Antimitotic and antimutagenic action of the Hymenaea stigonocarpa bark on dividing cells
MX2017014092A (es) Metodo para obtener una biomasa de una microalga de la especie tetraselmis chuii enriquecida en superoxido dismutasa (sod).
BR112016005817B8 (pt) Sistema e processo para extração de óleo de palma
BR112016006383A2 (pt) método de extração de proteína
BRPI1015432A8 (pt) Composição e método para melhorar a saúde vascular
CO2017010352A2 (es) Método para la elaboración de un extracto hidrosoluble de una biomasa vegetal
ES2570727T3 (es) Procedimiento de preparación de una mezcla que comprende semillas de una planta del género Theobroma
MD328Y (en) Process for presowing treatment of sweet pepper seeds
BR112018005847A2 (pt) composição de lipídeo de planta para estimular o crescimento de cabelo, método para estimular o crescimento de cabelo e uso dos referidos lipídeos de planta
BR112016014334B8 (pt) Método para incrementar a produção de flores, sementes e/ou frutas de uma planta, uso do micro-organismo colletotrichum tofieldiae e/ou meios de filtrado do dito micro-organismo
MX2016007973A (es) Composicion topica que comprende ingredientes naturales para el alivio de moretones o hematomas en la piel y uso de la misma.
WO2011038472A8 (pt) Estrato vegetal padronizado, processo para preparaçâo de extrato de plantas do gênero sclerolobium, composiçâo cosmética, composição farmacêutica e uso do referido extrato
BR102013000135A8 (pt) composição conservante antimicrobiana e seus usos
Ribo et al. Characterization of Phenolic Composition and Antioxidant Activity of the Leaf and Stem Extracts of Water Spinach (Ipomoea aquatic Forsk.)
PT110047A (pt) Rocesso para preparação de extratos aquosos bioativos de plantas aromáticas
BR132014030867F1 (pt) Compostos obtidos a partir de extratos da arrabidaea brachypoda e composições farmacêuticas compreendendo os mesmos
Taviano et al. Comparative study of biological activities of methanol and aqueous leaves extracts of five Juniperus L.(Cupressaceae) species growing in Turkey
Pereira et al. Characterization of phenols in salvia elegans and salvia greggii
Ebrahimifakhr et al. Total phenol and flavonoid content and antioxidant activity of methanolic extract from Perovskia abrotanoides Karel at different stages of plant growth and development
Afshaki et al. Antioxidant activity of different fractions from Crataegus persica extract
EA201400612A3 (ru) Фиточай на основе цистанхе

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2754 DE 17-10-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.